Type 1 Diabetes

Results of a 15-year cohort study found waist to height ratio was associated with increased risks of severe diabetic eye disease among individuals with type 1 diabetes.

Ezio Bonifacio, PhD, addresses barriers inhibiting widespread screening for type 1 diabetes (T1D), and offers insights on whether all individuals should be screened, or only those known to be at genetic risk for the disease.

A team of Australian researchers created and validated a model that may boost efficiency of type 1 diabetes (T1D) progression screening.

Camillo Ricordi, MD, FNAI, discusses some of the potential risks faced by patients with type 1 diabetes who undergo islet transplantation.

Leslie Eiland, MD, offers insights on whether use of certain technologies among patients with type 1 diabetes (T1D) will continue after the pandemic ends.

Results of a Swedish retrospective cohort study showed reduced rates of type 1 diabetes-related amputations over the past 2 decades.

Results of an Australian study highlight the changes that occur in the gut microbiome of pregnant patients with type 1 diabetes.

Aleksandar Kostic, PhD, an assistant professor of microbiology at Harvard Medical School, outlines what needs to happen next in his research developing a type 1 diabetes (T1D) vaccine.

Findings indicate that youth with type 1 diabetes may benefit from limiting fat intake.

Ezio Bonifacio, PhD, describes the benefits of screening children for type 1 diabetes and what preventive interventions may be possible.

Ann Goebel-Fabbri, PhD, a clinical psychologist in Boston, Massachusettes, dispels common misconceptions involving eating disorders among patients with type 1 diabetes.

Researchers revealed exposure to air pollution increases the risk of severe hypoglycemic episodes among youth with type 1 diabetes (T1D) in Germany.

JDRF, the world's largest nonprofit funder of type 1 diabetes research, announced the appointment of Shereef Elnahal, MD, to its research committee.

Mary Pat Gallagher, MD, of NYU Langone Health, outlines why young individuals should be vaccinated against COVID-19 and Finnish data on increased rates of type 1 diabetes (T1D) seen during the pandemic.

In a recently published review, authors assessed the relationship between poor bone health and type 1 diabetes (T1D) and outlined potential mechanisms that may account for the association.

Camillo Ricordi, MD, FNAI, outlines the current status of islet transplantation for patients with type 1 diabetes in the United States.

Leslie Eiland, MD, outlines some of the challenges of delivering optimal care to patients with type 1 diabetes (T1D) living in rural America.

New research shows central obesity is associated with an increased risk of poor heart failure outcomes among those with type 1 diabetes.

The designation means that pharmacists can switch patients to the less-expensive version of insulin without seeking approval from the clinician.

Aleksandar Kostic, PhD, an assistant professor of microbiology at Harvard Medical School, explains how a microbially targeted vaccine may prevent type 1 diabetes (T1D).

In a new review, researchers assessed the negative impacts of glycemic variability on cognitive function and brain structure among youth with type 1 diabetes.

Ezio Bonifacio, PhD, explains factors associated with childhood type 1 diabetes incidence and why more research is needed among minority populations.

In Germany, rates of diabetic ketoacidosis (DKA) seen at time of type 1 diabetes (T1D) diagnosis were stable throughout the past 2 decades.

Ann Goebel-Fabbri, PhD, a clinical psychologist in Boston, Massachusettes, discusses how limited research on patients with type 1 diabetes (T1D) and eating disorders hinders progress on developing effective interventions.

Mary Pat Gallagher, MD, of NYU Langone Health, discusses research needed to better understand how COVID-19 impacts individuals with diabetes.